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H deficiency in two brothers with atypical dense intramembranous
deposit disease. We report an H deficiency in two Algerian brothers who
had early—onset glomerulonephritis. In addition, one suffered from
serious lung infections. The H deficiency was defined by undetectable
C1150 and AP5O, and low levels of H, C3 and B (less than 10% of normal
levels). I and classical pathway components, including C4-bp were
normal. CR1 was present on both patients' erythrocytes. No nephritic
factor or other circulating alternative pathway activator was detected.
The parents, who are first cousins, and a healthy brother and sister had
half—normal levels of H. These findings favor an autosomal recessive
transmission of the H defect. Although by electron microscopy renal
biopsies from both patients were typical for dense intramembranous
deposit disease, immunofluorescence microscopy showed an atypical
pattern with abundant granular C3 deposits within the mesangium and
along the capillary walls. Alternative pathway activators, possibly
related to dense deposits, may allow the formation of membrane—as-
sociated C3/C5 convertases, unusually stable in the absence of H, since
C5, C6, C7, C8 and C9 levels were decreased in both patients. This
observation may represent an interesting clue to the relationship
between nephritic factor, alternative pathway activation, and dense
intramembranous deposit disease.
Numerous studies have emphasized the importance of the
proteins, H (f31H globulin) and I (C3b inactivator, C3bINA or
KAF), in the control of the alternative pathway of complement
[1—3]. I deficiency reported in a few children is associated with
an increased frequency of infections [4]. To our knowledge,
only two families with homozygous H deficient siblings have
been described [5, 6].
The present paper reports another family with a genetic H
deficiency. Two brothers, having very low H levels, presented
early—onset, atypical intramembranous dense deposit disease.
In addition, one had frequent and serious respiratory tract and
lung infections. The parents, who are first cousins, had
hall—normal H levels. Half—normal H levels were also found in
a healthy brother and sister. This observation may represent an
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interesting clue to the relationship between alternative pathway
activation and glomerulonephritis.
Case reports
The family tree is shown in Fig. 1. The findings concerning
the two brothers are described in detail. Other relevant family
information follows.
Case 111-3. This boy, born on December 8, 1978 after an
uncomplicated pregnancy and delivery, had a birth weight of
3.5 kg. Immunizations were performed. At the age of 14
months, isolated microscopic hematuria was detected after an
episode of vomiting, diarrhea, and dysuria. Nine months later
he had a fever, sore throat, and macroscopic hematuria, and his
blood pressure ws 140/90 mm Hg. In August 1981, another
throat infection was accompanied by proteinuria, microscopic
hematuria and transient elevated blood pressure. Urine samples
were normal one month later. In May 1982, macroscopic
hematuria was again noted after a sore throat and he was
admitted for evaluation. His weight was 14 kg (—1/2 sD), height
96 cm (—1/2 SD) and blood pressure 110/70 mm Hg. Physical
examination was unremarkable except for the presence of large
tonsils. Urinary protein excretion was 0.20 g/liter with 255,000
erythrocytes/min. Within a few days, urine samples were nor-
mal. Renal function, intravenous urography and echography
were normal. Two months later, macroscopic hematuria fol-
lowed diarrhea and fever. His hemoglobin level was 10.3 gldl,
MCV 84 ji and reticulocytes 0.1%. Serum iron was 6.2
mol/liter and haptoglobin 282 mg/dl. The following values
were within normal ranges: serum creatinine, sodium, potas-
sium, chloride, total protein, protein electrophoresis, aminoac-
idemia and aminoaciduria, immunoglobulin levels, folate con-
centration, urine and stool cultures. Iron therapy was started
and the hemoglobin level rose to 11.6 g/dl and serum iron to 14.9
mol/liter within two months. Adenoidectomy and tonsillec-
tomy were performed. In February, 1983, he had the chicken
pox, and one month later pharyngitis. Both infections were
accompanied by macroscopic hematuria. In October 1983, he
had a fever, cough, conjunctivitis, herpes virus labial infection,
and macroscopic hematuria. A few days later, proteinuria was
0.50 g/liter with 400,000 erythrocytes/min and renal function
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Fig. 1. Pedigree of the family. H levels are given below individual
symbols. Symbols are: (4) II) proposed heterozygotes; (•) proposed
homozygotes; (0 El) not tested; (0) deceased.
was normal. A renal biopsy was performed. The following
months were marked by the occurrence of otitis and then the
mumps, both of which were associated with macroscopic
hematuria. At the last examination, at the age of five years and
four months, his weight was 17 kg (—1/2 SD), his height 108cm
(—1/2 SD) and his blood pressure 100/60 mm Hg. His urine was
normal.
Case 111-5. This boy, born on July 8, 1982 after an uncom-
plicated pregnancy and delivery, had a birth weight of 2.7 kg.
Initial immunizations were performed. Vomiting and failure to
gain weight were noted at three months of age. He was admitted
for evaluation of macroscopic hematuria noted at 4-1/2 months
of age. His weight was 5.2 kg (--2 SD) and his blood pressure
was normal. Laboratory studies showed: hemoglobin level 8.8
g/dl, hematocrit 22%, white blood cell count 22,600/mm3 with
53% neutrophils, serum creatinine 40 mol/liter, sodium 138
mEq/liter, potassium 4.5 mEq/liter, calcium 92 mg/liter,
phophorus 41 mg/liters, and total protein 66 g/liter. Intermittent
macroscopic hematuria was noted the following month and he
was readmitted at six months of age. Weight was 5.540 kg (—2.5
SD) and height 64 cm (—-1 SD). His blood pressure was 80/40 mm
Hg. He appeared pale. Physical examination showed a large
anterior fontanelle with protruding low set ears and a hooked
nose. A right otitis media was detected and a chest X-ray
showed two dense areas in the right lung. Both infections
responsed to antibiotics. Macroscopic hematuria persisted and
the 24-hour protein excretion was 0.4 g. Hemoglobin was 7,6
gIdl with a reticulocyte count of 0.2%. Serum iron was Spmol/
liter. Hemoglobin electrophoresis, vitamin B12 and folate con-
centrations were normal. Serum creatinine was 45 tmol/liter,
sodium 135, potassium 4, chloride 99, carbon dioxide 25.5
mEq/liter, respectively. Calcium was 2.55 mmol/liter, phospho-
rus 2.05 mmol/liter, alkaline phophatases 4000 nKat/liter and
the 24—hour urine calcium excretion 0.43 mg/kg. On electropho-
resis, serum albumin was 3.39, al globulin 1.3, a2 globulin 1.03,
/3-globulin 0.65 and y-globulin 0.81 g/dl, respectively. Intrave-
nous urography and echography were normal. Bone x-rays
showed moderate osteoporosis.
A renal biopsy was performed in January 1983. Therapy with
iron and vitamin D was started. One month later, he had the
chicken pox. Subsequently, he was severely ill with bilateral
otitis and bronchitis; blood culture grew Escherichia Coil.
Within a few days, the infections responded to antibiotics.
During the following year the child, living in Algeria, showed
numerous upper and lower respiratory tract infections. Further-
more, anorexia and frequent vomiting were noted.
Again in France, he was admitted at the age of one year and
10 months. He weighed 7.320 kg (—3.5 SD) and measured 75.5
cm (—2 SD). Psychomotor development was retarded. Physical
examination showed a pale, malnourished, mildly dehydrated
child. Crepitations were audible in both lungs and chest x-rays
showed bilateral dense patches. The child received antibiotics
and showed substantial clinical improvement. His hemoglobin
level was 5.4 g/dl and serum iron 5 mol/liter. His platelet count
was 553,000/mm3 and white blood cell count 38,600/mm3 with
88% neutrophils. He was transfused with red blood cells.
Various analyses (thyroxine and TSH, Coombs test, cold
agglutinins, glucose-6-phosphate dehydrogenase concentration,
dl anti-trypsin serum level, sweat test, stool culture, xylose
absorption test, steatorrhea, biopsy of the small intestinal
mucosa) were performed. Results were reported to be within
normal limits. Serum creati nine was 43 mol/liter, sodium 131,
potassium 3.9, calcium 2.2, phophorus 1.05 mmol/liter, respec-
tively. Serum protein was 6.5 g/dl. Intermittent macroscopic
hematuria was noted and urine culture grew Proteus. The IgG
concentration was 7.7, IgA 0.83 and 1gM 1.41 g/liter, respec-
tively. Therapy with iron and vitamin D was pursued.
The following months were marked by frequent episodes of
pulmonary infections which responded to antibiotics. Macro-
scopic hematuria was nearly constant. Proteinuria varied be-
tween 0.5 and 1 g/day, serum creatinine between 16 and 30
mol/liter, and creatinine clearance between 90 and 70 mu
mn/1.73m2. A second renal biopsy was obtained one year and
10 months after the first one, Adenoidectomy was performed.
At 2-1/2 years, after several months of increased caloric intake,
he weighed 10.300 kg (—2 SD) and measured 86 cm (—1.5 SD).
Hemoglobin was 10.8 g/dl and the hematocrit 31%.
['amity history. The family is of Algerian origin. The parents
(Fig. 1, 11—1 and 11—2) are first cousins; their fathers were
brothers. Urinalysis, complement and HLA studies were per-
formed in 1983.
Case 11—1. The medical history of the mother, who was born
in 1958, is unremarkable. Urinary protein excretion was 0.15 to
1.1 g/liter with 10,000 to 100,000 erythrocytes/min.
Case 11—2. The father born in 1956, had a history of lithiasis.
Case III—!. A daughter died of dehydration at six months of
age.
Case 111—2. A daughter, born in 1976, had a retarded
psychomotor development. Urinalysis was normal.
Case 111—4. A son born in 1980. Urinalysis was normal.
Case 111—6. A son born in 1984.
Methods
Renal tissue was obtained by percutaneous biopsy performed
after intravenous pyclography. For light microscopy, the tissue
was fixed in Dubosy—Brazil fluid, then in 15% formalin, embed-
ded in paraffin, and 2 to 3 m sections were cut. Sections were
stained by hematoxylin and eosin, periodic-acid Schiff, Masson
trichrome stain and silver impregnation (Wilder's technique).
For immunofluorescence microscopy, tissue was snap frozen in
nitrogen liquid and 2 m sections were cut in a cryostat.
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Sections were incubated with commercial (Behringwerke Lab-
oratories, Marburg, FRG) monospecific, fluoresceinated im-
mune sera against human IgA, IgG, 1gM, Clq, C4, C3, fibrin
and albumin. In addition, sections of one biopsy specimen
(patient 111-5, second biopsy) were overlaid with monoclonal
mouse antibodies to human C5b-C9 neoantigens, with rabbit
antibodies to human H, and with rabbit antibodies to human
C3b receptor. Sections were further incubated with fluorescein-
ated sheep anti-mouse IgG (Serotec, England), sheep Fab'
anti-rabbit IgG (Byosis, France) and goat anti-rabbit IgG
(Institut Pasteur, France), respectively. Slides were viewed
with a Leitz orthomat microscope (Leitz Inc., Heerbrugg,
Switzerland) using an HBO 200 lamp and a vertical illuminator.
For electron microscopy, renal tissue was fixed in glutaral-
dehyde, post-fixed in osmium tetroxide and embedded in Epon.
Ultrathin sections were cut using a Reichert OMU2 ultramicro-
tome (Reichert—Jung, Paris, France). They were stained with
uranyl acetate and lead citrate. Silver staining methods were
also performed for light and electron microscopic examinations.
Thin sections were studied with a Siemens Elmiskop 101
electron microscope.
Blood was allowed to clot at room temperature, and then the
serum was removed and stored at —70°C until analyzed. CH5O
and alternative pathway—dependent hemolytic assay (AP5O)
were performed as described previously [7, 8]. Immunochemi-
cal quantitation of complement components was carried out by
radial, electroimmunodiffusion, or laser nephelometry, using
monospecific antisera (Hyland, Costa Mesa, California, USA,
Behringwerke, and Dako Laboratories, Copenhagen, Den-
mark). H was measured by radial immunodiffusion, rocket
electrophoresis, and by a radioimmunoassay measuring the
inhibition of binding of '251-labeled purified H and anti-H
antibodies. I and C4-bp were measured by semi-quantitative
double diffusion analysis using monospecific antisera.
The presence of alternative pathway nephritic factor
(C3NeF) in the patients' sera was assessed by its ability to
activate C3 in normal serum in the presence of Mg-EGTA [9,
10]. Serum from patient 111-5 was fractionated on DEAE
trisacryl (Biorad Laboratories, Richmond, California, USA)
and C3NeF was further tested in IgG-containing fractions by
the alternative—pathway C3 convertase—stabilization assay [111.
B [12], D [131 and C3 [14] were purified as described elsewhere.
C3 fragments on the patients' red cells were detected by
agglutination assays using monospecific anti-C3c (Dako Labo-
ratories) or anti-C3d (Netherland Red Cross) antisera.
The immune adherence receptor CR1 on the patients' eryth-
rocytes was detected by agglutination with C3b-bearing eryth-
rocyte ghosts (antibody—coated sheep erythrocytes incubated
and lysed after eight minutes at 37°C in undiluted normal human
serum). This agglutination reaction was totally inhibited by a
polyclonal anti-CR! antibody.
HLA-A and B antigens were determined by classical micro-
lymphocytoxicity (M.F. Reznikoff, C.N.T.S., Paris, France).
Factor B typing was performed by high—voltage electropho-
resis and subsequent immunofixation. C4 typing was performed
by electrophoresis of samples previously incubated with
neuraminidase and followed by immunofixation. C2 typing was
determined by isoelectric focusing and immunoblotting [151.
Fig. 2. Patient 111-3. Light microscopy. Trichrome stain. x 235. The
thickening of the capillary walls is nearly diffuse and associated with an
increase in the mesangial matrix.
Results
Pathology
Case 111-3: Light microscopy. Sections contained an average
of 40 glomeruli. Two were small and sclerotic. Other glomeruli
showed diffuse but irregular thickening of the capillary walls
due to both parietal deposits and double—contour. Increased
mesangial stalks were associated with moderate mesangial cell
proliferation (Fig. 2). The interstitium was normal. A few
tubules contained red blood cells or showed thickened base-
ment membranes. Arteries were normal.
Electron microscopy. Four glomeruli were studied. There
was a diffuse but irregular thickening of the basement mem-
brane due to the presence of electron—dense, homogeneous
argyrophilic deposits. These deposits were discontinuous and
located within the basement membrane, more precisely at its
internal part. They were seen around all capillary loops and
mesangial stalks and were associated with segmental mesangial
interposition. No subepithelial deposits were observed. Focal
effacement of foot processes was present. An irregular increase
in the mesangial matrix was associated with the presence of
numerous electron—dense, homogeneous, argyrophilic mesan-
gial deposits. Occasional monocytes were observed within the
capillary lumens. The interstitium was unremarkable.
Immunofluorescence microscopy. With anti-C3 serum, a dif-
fuse fluorescence of the entire tufts was observed. Abundant,
bright, variably—sized granular deposits were present within the
mesangial stalks and the capillary walls, which were often
thickened. Rare, segmental "linear" deposits were observed in
the glomerular basement membranes. Deposits contained only
C3. No deposits were seen along the tubular basement mem-
branes or within arteries.
Case 111-5, first biopsy: Light microscopy. Sections contained
an average of 25 glomeruli. They showed an irregular and
moderate increase in mesangial cells and an important increase
in the mesangial matrix. Endothelial cells were swollen. Poly-
morphonuclear cells and monocytes were frequently observed
in the capillary lumens. The double-contour appearance of the
capillary walls was occasional (Fig. 3). Two glomeruli showed a
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Fig. 3. Patient 111-5. First renal biopsy. Light microscopy. Trichrome
stain. x 235. The important but irregular increase in the mesangial
matrix is accompanied by a slight mesangial proliferation and an
occasional thickening of the capillary walls.
small sclerotic lesion, one of which was crowned by large
epithelial cells. There was a moderate fibroedema containing
scattered mononuclear cells, Several proximal tubules con-
tained enormous hyaline casts or red blood cells. Arteries had
swollen endothelial cells.
Immunofluorescence microscopy. With anti-C3 serum, scat-
tered, bright and granular deposits were present in the mesan-
gial areas, whereas the capillary walls had a diffuse "linear"
appearance. No tissue was available for electron microscopy.
Second biopsy: Light microscopy. Sections contained an
average of 20 glomeruli. They all showed mesangial cell prolif-
eration and increased mesangial matrix. Glomerular basement
membranes were diffusely thickened but the double—contour
appearance of the capillary walls was occasional. Endothelial
cells were swollen and numerous circulating cells were present
in the capillary lumens. Epithelial cells were hypertrophied.
Segmental thickening of the Bowman's capsules was present.
The interstitium showed moderate fibrosis and the presence of
mononuclear cells. Arteries has swollen endothelial cells.
Electron microscopy. In the seven glomeruli studied, diffuse
changes involving capillary walls and mesangial stalks were
observed (Figs. 4 and 5). Capillary walls were irregularly
thickened by electron—dense, argyrophilic, homogeneous de-
posits located within the basement membranes. Focal dou-
ble—contour was present and frequently characterized by the
presence of the same type of deposits as those found within the
mesangial expansion. Occasional enlargement of the lamina
rara interna was observed. Some capillary loops were, how-
ever, lined by a normal glomerular basement membrane. Ef-
facement of foot processes was only occasional. Marked but
irregular mesangial proliferation was present in five glomeruli
and absent in two. In all glomeruli, an increase in the mesangial
matrix with dense mesangial deposits was noted. Numerous
circulating cells, especially monocytes and polymorphonuclear
cells, were present in the capillary lumens. Cells were also
found within the mesangial stalks or between the basement
membrane and the endothelial cells. No deposits were observed
within Bowman's capsules, tubular or vascular basement mem-
branes. Interstitial edema and fibrosis, containing circulating
cells, that is, monocytes, lymphocytes, plasmocytes, and occa-
sional mastocytes, were observed. Small lymphocytes were
also present between tubular epithelial cells.
Immunofluorescence microscopy. An increased deposition of
C3 was noted, Abundant, bright, granular, variably—sized C3
deposits were present in nearly all mesangial stalks and capil-
lary walls which were frequently thickened (Fig. 5). A few
segmental "linear" C3 deposits along basement membranes
were seen. No C3 deposits were observed along the tubular
basement membranes or within arteries. Bright deposition of
C5b-9 and H antibodies were observed within mesangial stalks
and thickened capillary walls. Clusters of C5b-9 were observed
along most tubular basement membranes. Bright staining with
anti-C3b receptor antibody was seen on all glomeruli.
Complement studies
The complement profiles are summarized in Table 1. In both
patients, CHSO and AP5O were undetectable. Repeated testing
of different specimens revealed persistent low levels of C3, B
and H. The H level was less than 10% of the normal. The results
obtained by the three methods were almost identical. In addi-
tion, the CS level was low in both patients; C6, C7, C8 and C9
levels were decreased but to a lesser degree. Clq, Clr, Cls and
C4 concentrations were normal, I and C4-bp were present in
normal amounts in both patients. C3NeF was absent in all sera.
The patients' red cells strongly agglutinated with anti-C3d
antibodies but did not react with anti-C3c. CR1 dependent
immune adherence was normal for both patients.
H was also reduced to half—normal levels in the other
members of the family. CH5O, AP5O and serum levels of C3 and
B were within the normal ranges in the parents and the healthy
brother and sister. CS was normal in both parents and slightly
decreased in the other children (111-2 and 111-4).
HLA, Bf and C4 typing
Typing was as follows:
II-! (BF F/Fl; C2 C/C; C4A3B1/A3B1)
11-2 (BF SISO.7; C2C/C; C4A2B1,2/A2BI; HLA-A28,
B l4/A9,B 12)
111-2 (BF F/S; C2 C/C; C4A3BI/A2B1,2; HLA-A29,
8w21/A28, B14)
111-3 (BF*; C2C/C;C4A3B 1/A2B1; HLA-A9,B 12/A29,Bw21)
111-4 (BF F/S; C2 C/C; C4A3B1/A2 Bl,2; HLA-A29,
Bw21/A28, B14)
111-5 (HLA-A9, B12/A29, Bw21)
*BF pattern not interpretable: factor B very low.
Discussion
The present paper reports on an Algerian family in which two
brothers have early onset glomerulonephritis with C3 deposits
and low levels of H (less than 10% of the normal level). Family
study and laboratory investigations favor an autosomal reces-
sive transmission of the H defect. The parents are first cousins
and since both have half—normal H value, may be considered to
be heterozygotes. Two healthy sibs are also heterozygotes.
Duplication at the C4B locus was disclosed in the mother and
the two healthy sibs. This duplication of the type C4B1,2, is
always associated with C2C, BFS, C4A and HLA-B14, which
were also observed in our family [161. In addition, all members
of the family typed for C2 had the common C2 C variant [171.
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Fig. 4. Patient 111-5. Second renal biopsy. Electron micrograph. Uranyl acetate and lead citrate. x 4000. Electron dense homogeneous deposits
are present within the peripheral capillary loops and within the mesangial matrix and mesangial expansions. Note the presence of numerous
circulating cells.
Although a clinical syndrome is not manifested by all indi-
viduals, homozygous (or occasionally heterozygous) comple-
ment deficiencies are associated with clinical syndromes (that
fall into three categories: collagen—vascular diseases, mostly of
the systemic lupus erythematosus type, increased susceptibility
to infections, and glomerulonephritis [18—201. There is no
distinct clinical entity associated with H deficiency. Two Asian
brothers with homozygous H deficiency (both having residual H
like our patients) have been reported by Thompson and
Winterborn [5]. One had hemolytic and uremic syndrome at the
age of eight months, whereas his three—year—old brother was
clinically healthy. Four years later, they are perfectly well and
have not presented recurrent infections (Winterborn, personal
communication). In the family reported by Brai, Misiano, and
Hauptmann [6], three of four children have homozygous H
deficiency (less than 1% of normal). Moreover, the father and
two of the H-deficient siblings have a partial C2 deficiency. One
of the children with combined deficiency is affected by systemic
lupus erythematosus with nephritis. The other two H-deficient
children had meningitis and several viral infections, respec-
tively.
In our two patients, the renal disease was discovered at 14
and four months of age, respectively, and was essentially
characterized by hematuria. The eldest had recurrent episodes
of macroscopic hematuria occuring during the course of infec-
tions, but he did not seem to have an excessive number of
infections. The second had repeated respiratory tract and lung
infections and showed a nearly persistent macroscopic hema-
tuna. The mother, considered heterozygotes, had microscopic
hematuria and proteinuria, but further investigations could not
be performed. Glomerular symptoms have also been reported in
two families having partial H deficiency [21]. In one of them,
the index case had vasculitis, proteinuria, and thrombocyto-
penia (rendering a renal biopsy impossible), whereas IgA
nephropathy was demonstrated in two sisters from a second
family.
Renal biopsies from our two patients showed increase in the
mesangial matrix associated with varying degrees of mesangial
cell proliferation, segmental mesangial interposition, thickening
of the capillary walls due to electron—dense, homogeneous,
argyrophilic deposits located within the basement membrane
and abundant, dense mesangial deposits. Neither subepithelial
nor subendothelial deposits were observed. Thus, when exam-
ined by electron microscopy, renal biopsies from both patients
were typical for dense intramembranous deposit disease [22,
23]. However, the electron dense material, generally found in
the basement membranes of the Bowman's capsules and of the
tubules in dense intramembranous deposit disease, was not
present. Moreover, dense deposits are usually recognized by
immunofluorescence microscopy which reveals the presence of
mesangial, well delineated, round nodules of variable number
and size, intensely stained with anti-C3 serum, as well as
interrupted, ribbon—like deposits of C3 along the glomerular
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Fig. 5. Patient 111-5. Second renal biopsy. Electron micrograph. Sil-
ver methenamine impregnation. x 3800. The capillary wall is irreg-
ularly thickened by the presence of dense argyrophilic intramembran-
ous deposits.
Bowman' capsules [221. In our patients, the extremely abun-
dant and granular C3 deposits located in the mesangium and
along the capillary walls which gave a diffuse fluorescence to
the entire tufts, were clearly distinct from the typical pattern of
dense intramembranous deposit disease and were rather sug-
gestive of membranoproliferative glomerulonephritis with sub-
endothelial deposits containing only C3 [24, 25]. As in most
proliferative glomerulonephritis, the pattern of staining of the
C3b receptor was normal [26], The finding of an extensive
parietal and mesangial deposition of C5b-9 neoantigens and H
antigens in areas of C3 deposition as well as the presence of
C5b-9 in tubular connective matrices without detectable im-
mune deposit are in agreement with previous observations [271.
The presence of residual H in the serum probably allows
glomerular H deposition.
This atypical form of dense intramembranous deposits dis-
ease has not been previously described in patients having
complement deficiency. In most instances, the glomerulone-
phritis, associated or not with systemic lupus erythematosus,
presents deposits containing immunoglobulins, early comple-
ment components and C3 [20, 28, 291. However, two comple-
ment deficient patients with isolated C3 glomerular deposits
have been reported. One had C3 deficiency and membranopro-
liferative glomerulonephritis, but electron microscopy was not
performed [30]. The second had an inherited defect in C3
convertase and, by electron microscopy, the C3 deposits were
shown to be subepithelial [291.
In our patients, the serum complement profile with decreased
levels of C3 and B and normal levels of classical pathway
components is consistent with an in vivo activation of the
alternative pathway despite the absence of C3NeF or other
circulating alternative activators. These results, similar to those
previously described [51, show that the lack of circulating H is
sufficient to induce complement activation by deregulating the
normal control mechanisms of the alternative pathway. The
cellular C3b receptor, CR1, present mainly on erythrocytes, is
known to be able to replace H in its alternative pathway
regulating activity [31]. Both CR! and H prevent the formation
of the alternative pathway convertase C3b, Bb and allow C3b
degradation by I [32]. Our patients' erythrocytes and podocytes
appeared to have normal CR!. This CR1 allowed the cleavage
of the erythrocyte—bound C3b into C3d-g, but was not sufficient
to prevent fluid phase activation in the absence of H.
C5-C9 levels were decreased in our patients and in the
patients reported by Brai, Misiano and l-lauptmann [6], unlike
the two previously described H-deficient cases [5]. Fluid phase
activation of the alternative pathway does not lead to CS
cleavage, since CS activation requires the presence of a C31C5
convertase and a CS-binding C3b molecule, both bound to an
activating surface [33, 34]. Therefore, in vivo CS activation
suggests the existence, in our patients, of an alternative path-
way activating surface (possibly in the glomerulus) allowing the
formation on its surface of a C3/C5 convertase, which is
unusually stable in the absence of H. Although patients appear
to have normal glomerular CR1 which has H-like function, the
epithelial localization of CR1 would not allow to control com-
plement activation at the site of the deposits, that is, within the
mesangium and the glomerular basement membrane.
Therefore, we suggest that both children have an uncommon
form of dense intramembranous deposit disease. It is tempting
to hypothesize that an initial unknown glomcrular lesion led to
a local alternative pathway activation. The absence of control
protein (H) amplifies local C3 and C5-C9 activation. This
possible secondary pathogenetic role of a locally uncontrolled
alternative pathway activation may also be effective in typical
dense intramembranous deposits disease. Indeed, the presence
of C3NeF is somewhat similar to the lack of H, since C3NeF
protects C3 convertase against H action, and is thus able to
amplify any complement activation. However C5 [24] or C5-C9
[35] and the H level [Levy, unpublished results, 36, 371 are
normal in patients with dense intramembranous deposit disease
associated with C3NcF.
From the study of the two families, no relationship was
demonstrated between H deficiency and HLA typing. As has
been suggested by Rodriguez de Cordoba et al [38], the genes
for H, CR1 and C4-bp are closely linked and constitute a new
gene family independent of the major histocompatibility com-
plex, which contains the genes for C4, C2 and factor B, or of the
C3 locus. CR1, being localized on chromosome 1 [39], studies
using DNA techniques will probably allow an approach of the
molecular basis of the defect. The presence of H residual in our
patients favors the hypothesis of a specific regulatory defect in
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Fig. 6. Patient 111-5. Second renal biopsy.
Immunofluorescence microscopy. Anti-C3
serum. x 800. Bright and granular deposits
are observed in the mesangial areas and in the
capillary walls.
Table 1. CH50, AP50 and complement component concentrations in patients and family members.a
Patients Family
Normal
rangelI-i 11-2 111-2 111-4111-3 111-5
Clq" 100 100 100 110 100 100 70—130
C1r 85 80 95 85 85 85 70—115
CIsc 125 120 110 110 105 120 70—130
C4" 100 65 70 140 75 75 40—180
C3d 8 5 90 105 80 80 70—150
C5C 15 15 90 85 45 55 60—150
C6C 45 35 90 100 90 100 60—140
C7c 30 35 N.D. N.D. N.D. 60-1 10
C8C 45 35 105 80 95 120 60—140
C9° 30 20 75 100 85 65 70—150
B' 20 15 100 110 85 75 65—150
Hb 12 12 46 54 36 36 70-130
HC 9 45 55 40 40 70-130
W 6 9 N.D. N.D. N.D. N.D.
CH50 0 0 129 100 100 85 80—120
AP5Q 0 0 130 150 80 100 60—160
a I and C4-bp were present in all family members in normal amounts as assessed by semi-quantitative double diffusion analysis using
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